DPP4 and heart failure: However, it is noteworthy that no prior studies directly compared DPP4 inhibitors with SGLT2 inhibitors, and our finding that at a class level DPP4 inhibitors are associated with higher risk of heart failure hospitalization than SGLT2 inhibitors will be an important addition to the literature.